Bharat Biotech seeks nod for Phase-3 trials of nasal Covid-19 vaccine

z17 1

Bharat Biotech’s nasal vaccine, BBV154, has already completed Phase-2 trials with Covaxin. The proposed Ph-3 trials will cover those who have been administered with any two doses of the Covid-19 vaccine. Vaccine maker Bharat Biotech has sought regulatory nod to conduct Phase-3 trials of its nasal Covid-19 vaccine that can be used as a booster … Read more

Bharat Biotech seeks nod for phase-3 trials of intranasal COVID-19 vaccine as booster dose

Bharat Biotech

An intranasal vaccine as a booster dose would be easier to administer in mass vaccination campaigns and has the potential to prevent transmission. Bharat Biotech has sought the Drug Controller General of India’s approval to conduct phase-3 trials of its COVID-19 intranasal vaccine (BBV154) to use as booster dose, sources said on Monday. “The application … Read more

Bharat Biotech, Dunc Minh donate 2 lakh Covaxin doses to Vietnam

covaxin FE

The donation represents a gesture of goodwill to provide access to Bharat Biotech’s Covaxin to fight COVID- 19 pandemic across borders. The Republic of Vietnam will receive 2,00,000 doses of Bharat Biotech’s COVID-19 vaccine, a top official of the company said on Thursday. The announcement was made by Suchitra Ella, Joint Managing Director of Bharat … Read more

Bharat Biotech rolls out Covid-19 vaccine from Gujarat plant; supplies start in September

1 681

It was a matter of pride that the research and production of vaccines of two companies — Bharat Biotech and Zydus Cadila — took place in India, the minister said. Bharat Biotech on Sunday announced the commercial launch of the first batch of Covid-19 vaccine, Covaxin, from its Chiron Behring vaccine facility in Ankleshwar, Gujarat. … Read more

Covid-19: Bharat Biotech cancels $320-million vaccine supply contract with Brazil’s Precisa Medicamentos

covaxin FE

The reports had alleged that there were some irregularities associated with the hike in the vaccine price. In a surprising development, Hyderabad-based vaccine maker Bharat Biotech has cancelled the contract to supply its Coronavirus vaccine Covaxin to Brazil. The company in a statement issued on Friday said that it has terminated the contract to supply … Read more

Coronavirus in India: Covaxin phase 3 trial data shows 77.8% efficacy to reduce symptomatic COVID-19 cases

covaxin FE 2

Covaxin has not been granted permission to be used without restriction, even as Bharat Biotech had sought complete authorisation. Covaxin efficacy: Data from the phase 3 trials of Bharat Biotech’s Covaxin – India’s only indigenous coronavirus vaccine so far – has been shared by the manufacturer, and it shows that symptomatic COVID-19 cases can be … Read more

Covaxin phase 3 trial results out, Bharat Biotech says its Covid vaccine has 81% efficacy rate

Covaxin UK Variant

The DGCI had said that the decision to grant emergency approval to the vaccine maker was given on the basis of earlier phases of clinical trials. Bharat Biotech, the Hyderabad-based pharma major, has released the efficacy data of its Coronavirus vaccine ‘Covaxin’ on Wednesday. reported. According to news agency ANI, the company said that its … Read more

Bharat Biotech’s ultimate dream run: Hyderabad start-up to pharma giant, how this desi company made global impact

bhart1200

Soon after the company had been chosen by the DBT for the Rotavirus vaccine, the company shipped out the first batch of vaccine it had developed for Hepatitis B in the year 1999. (Credit: ANI) With the government regulator allowing the emergency use of the Covid-19 vaccine developed by Bharat Biotech, the Hyderabad-based company has … Read more

Coronavirus vaccine: Ready to begin vaccination in 10 days, waiting for final nod, says Health Ministry

covaxin 2

He also made it clear that the Covaxin vaccine will be administered to people under phase 3 trials and only after getting their prior consent. The Union Health Ministry has said that the centre and state governments were in a position to begin vaccination within 10 days of getting the approval from the regulator Drug … Read more

Covid-19 vaccine emergency use authorisation soon? SEC meets to consider Pfizer, Serum, Bharat Biotech requests

covaxin 5

Coronavirus Covid 19 vaccine emergency use authorisation: (Reuters/Representational Photo) Covid-19 vaccine emergency use authorisation: The Ministry of Health and Family Welfare informed on Wednesday that the Subject Expert Committee (SEC) in Central Drugs Standard Control Organisation (CDSCO) held a meeting to consider the Emergency Use Authorisation (EUA) request of Pfizer, Serum Institute of India (SII) … Read more